Age-Related Eye Disease Study 2 (AREDS2)

A nationwide study to determine whether a modified combination of vitamins and minerals can further slow the progression of vision loss from age-related macular degeneration (AMD), the leading cause of vision loss in the United States for people over age 60. Nearly 100 clinical centers are now seeking 4,000 study participants ages 50 - 85 who have AMD.

How Can I Participate?

• Find an AREDS2 Clinical Center

AMD Information for Patients

• English
• Spanish

News Release

• English
• Spanish

Images and Animations

Age-Related Eye Disease Study-Results

Other AMD Clinical Studies Supported by the NEI

• Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)
• Improving Function in AMD (IF-AMD)
• Submacular Surgery Trials (SST)